Avidin-pseudotyped viral vectors and their use

Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100, C435S455000, C435S456000, C424S199100, C424S093200, C536S023400

Reexamination Certificate

active

07393677

ABSTRACT:
The present invention pertains to an avidin-pseudotyped virus, and especially baculovirus, useful for delivery of foreign genes etc. The present invention also pertains to vectors comprising respective cassettes for pseudotyping, mammalian gene expression and insect gene expression in baculovirus.

REFERENCES:
patent: 5244805 (1993-09-01), Miller
patent: 5731182 (1998-03-01), Boyce
patent: 5789245 (1998-08-01), Dubensky et al.
patent: 6015694 (2000-01-01), Dubensky et al.
patent: 7018628 (2006-03-01), Sarkis et al.
patent: 2001/0049144 (2001-12-01), Rivera et al.
patent: 2003/0054010 (2003-03-01), Sebbel et al.
patent: 2004/0028653 (2004-02-01), Seed et al.
patent: WO 97 05266 (1997-02-01), None
patent: WO 99 09193 (1999-02-01), None
patent: WO 99/19500 (1999-04-01), None
patent: WO 00 77233 (2000-12-01), None
Horlick et al., “Rapid Generation of Stable Cell Lines Expressing Corticotropin-Releasing Hormone Receptor for Drug Discovery,” Protein Expression and Purification, 9, pp. 301-308 (1997).
Shoji et al., “Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors,” Journal of General Virology, 78, pp. 2657-2664 (1997).
Tomiyasu et al., “Gene Transfer in vitro and in vivo with Epstein-Barr Virus-Based Episomal Vector Results in Markedly High Transient Expression in Rodent Cells,” Biochemical and Piophysical Research Communications, 253, pp. 733-738 (1998).
Langle-Rouault et al., “Up to 100-Fold Increase of Apparent Gene Expression in the Presence of Esptein-Barr virus oriP and EBNA1: Implications of the Nuclear Import of Plasmids,” Journal of Virology, vol. 72, No. 7, pp. 6181-6185 (1998).
Zavada, “The Pseudotypic Paradox,” J Gen Virol, 63, 15-24 (1982).
Badie et al., “Combined radiation and p53 gene therapy of malignant glioma cells,” Cancer Gene Therapy, vol. 6, No. 2, pp. 155-162 (1999).
Airenne et al., “Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery,” Gene Therapy, 7, pp. 1499-1504 (2000).
Smith et al., “Redirected Infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens,” PNAS, vol. 96, pp. 8855-8860 (1999).
Kreda et al., “G-protein-coupled receptors as targets for gene transfer vectors using natural small-molecule ligands,” Nature Biotechnology, vol. 18, pp. 635-640 (2000).
Vinogradov et al., “Polyion Complex Micelles with Protein-Modified Corona for Receptor-Mediated Delivery of Oligonucleotides into cells,” Bioconjugate Chem, 10, pp. 851-860 (1999).
Lu et al., “Semliki Forst Virus Budding: Assay, Mechanisms, and Cholesterol Requirement,” Journal of Virology, vol. 74, No. 17, pp. 7708-7719 (2000).
Sanders, D.A. “No False Start for Novel Pseudotyped Vectors”Current Opinion in Biotechnology, 2002, pp. 437-442,vol. 13.
Raty, J.R. et al. “Enhanced Gene Delivery by Avidin-Displaying Baculovirus”Molecular Therapy, Feb. 2004, pp. 282-291, vol. 9, No. 2.
Williams, D.A. et al. “Gene Therapy-New Challenges Ahead”Science, Oct. 2003, pp. 400-401, vol. 302.
Phillips, A.J. The Challenge of Gene Therapy and DNA DeliveryJournal of Pharmacy and Pharmacology, 2001, pp. 1169-1174, vol. 53.
Chapple, S.D.J et al. “Non-Polar Distribution of Green Fluorescent Protein on the Surface ofAutographa californicaNucleopolyhedrovirus using a Heterologous Membrane Anchor”Journal of Biotechnology, 2002, pp. 269-275, vol. 95.
Borg, J. et al. “Amino-Terminal Anchored Surface Display in Insect Cells and Budded Baculovirus using the Amino-Terminal End of Neuraminidase”Journal of Biotechnology, 2004, pp. 21-30, vol. 114.
Lung, O.Y. et al. “Ac23, an Envelope Fusion Protein Homolog in theBaculovirus californicaMulticapsid Nucleopolyhedrovirus, Is a Viral Pathogenicity Factor”Journal of Virology, Jan. 2003, pp. 328-339, vol. 77, No. 1.
Loisel, T.P. et al. “Recovery of Homogeneous and Functional Beta-2-Adrenergic Receptors from Extracellular Baculovirs Particles”Nature Biotechnology, Nov. 1997, pp. 1300-1304, vol. 15, No. 12, Abstract only.
Urano, Y. et al. “A Novel Method for Viral Display of ER Membrane Proteins on Budded Baculovirus”Biochemical and Biophysical Research Communications, 2003, pp. 191-196, vol. 308.
Kazuyuki, M. et al. “A Combinatorial G Protein-Coupled Receptor Reconstitution System on Budded Baculovirus”Journal of Biological Chemistry, Jul. 2003, pp. 24552-24562, vol. 278, No. 27.
Ikuo, H. et al. “Selective Reconstitution and Recovery of Functional γ-Secretase Complex on Budded Baculovirus Particles”Journal of Biological Chemistry, Sep. 2004, pp. 38040-38046, vol. 279, No. 36.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Avidin-pseudotyped viral vectors and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Avidin-pseudotyped viral vectors and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Avidin-pseudotyped viral vectors and their use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2779794

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.